Viyash Scientific
VIYASHNSE

Viyash Scientific

₹246.06-1.48 (0.60%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
244.62
Today’s high
262.50
52 week low
166.00
52 week high
268.70
Open price
248.80
Previous close
247.54
Live volume
38,87,387
Lower circuit
196.85
Upper circuit
295.27

Fundamentals

Market Cap
₹10,747Cr
ROE
7.07%
P/E Ratio(TTM)
47.86
EPS(TTM)
5.14
P/B Ratio
3.69
Dividend Yield
0.00%
Industry P/E
34.13
Book Value
66.63
Debt to Equity
0.17
Face Value
2

Financial performance

Quarterly
Yearly
All Financials
MAR '26
Revenue (Cr)
₹936
+7.28%
Profit (Cr)
₹66.38
+36.81%
02505007501k
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Revenue growthValue
1Y (TTM)+132%
3Y CAGR+3%
Profit growthValue
1Y (TTM)+539%
3Y CAGR-10%

About

SeQuent Scientific Limited stands as India's foremost animal health player, demonstrating an expanding global presence with state-of-the-art manufacturing capabilities across multiple continents. Its core vision is to establish itself as a premier integrated animal health company dedicated to delivering high-quality veterinary solutions around the world. The company's mission focuses on competitively delivering quality products while upholding strict standards of quality, governance, and compliance in all its operations. It offers an integrated portfolio that includes Active Pharmaceutical Ingredients (APIs) and Finished Drug Formulations (FDFs) to meet the industry's evolving needs. Through its animal health brand Alivira, the company is focused on advancing veterinary care by offering solutions that promote the well-being of animals. The company maintains a vast global reach with product registrations across numerous dosage forms, serving customers in over 90 countries.;
CEO/MD
Mr. Rajaram Narayanan
Founded in
1985
NSE symbol
VIYASH

Shareholding Pattern

Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Promoters
61.31%
Retail And Others
27.76%
Mutual Funds
6.44%
Foreign Institutions
2.94%
Other Domestic Institutions
1.54%

Mutual Funds Invested (2)

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹1,343.80
-42.10 (3.04%)
L
    H
    18,628.2928.774.77
    ₹751.95
    -12.25 (1.60%)
    L
      H
      18,624.4231.33.66
      ₹1,006.35
      -5.30 (0.52%)
      L
        H
        16,021.6040.312.43
        ₹1,039.00
        -17.50 (1.66%)
        L
          H
          12,715.1922.533.82
          Livesquawk
          Viyash Scientific's Q4 net profit rose to ₹521M from a ₹262M loss YoY. Q4 revenue increased to ₹9.2B from ₹7.7B YoY.
          Livesquawk
          Viyash Scientific's Q3 net profit fell to ₹384M from ₹446M YoY. Q3 revenue rose to ₹8.6B, up from ₹7.7B YoY.
          2026
          19
          May
          Quarterly & Annual Result
          Release date
          5
          Feb
          Quarterly Result
          Release date
          2025
          14
          Nov
          Quarterly Result
          Release date
          8
          Aug
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks